The company offers a range of services to small, medium, and large biopharma companies, including strategy development, execution, and operations. They specialize in CDMO selection and oversight, and have successfully managed the entire CMC work for three new biologic molecular entities, from DNA generation to commercial manufacturing. Cilatus BioPharma was acquired by ProductLife Group in May 2023.